Skip to main content

Table 1 Mean and standard deviation of PVF and VI in % dog weight (N/N and N.s/N, respectively) applied on the diseased leg

From: Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs

Day

0

30

90

180

PVF ML

43.56 ± 0.73

49.21 ± 2.1

49.05 ± 1.51

53.2 ± 4.43

PVF LL

55.98 ± 0.62

53.96 ± 1.46

52.67 ± 1.91

51.53 ± 2.79

PVF S

47.40 ±1.43

47.74 ± 1.34

47.95 ±1.35

47.94 ± 1.65

VI ML

12.16 ± 0.72

13.75 ±1.17

13.71 ± 1.1

14.84 ± 1.29

VI LL

16.09 ± 1.01

15.51 ± 1.28

15.12 ± 1.45

14.83 ± 1.54

VI S

14.51 ± 0.47

14.62 ± 0.41

14.67 ± 0.42

14.67 ± 0.51

  1. PVF ML: peak vertical force in the more-lame limbs. PVF LL: peak vertical force in the less-lame limbs. VI ML: vertical impulse in the more-lame limbs VI LL: vertical impulse in the less-lame limbs. PVF S: peak vertical force in the control group. VI S: vertical impulse in the control group.
  2. Data are shown for each day of observation.